Partners
Launch of Immunostep's New Reagent for CAR T Cell Detection
Immunostep introduces an innovative reagent for CAR T cell detection, enhancing precision and efficiency in cancer immunotherapy.
Healthcare
Access to innovation
Drug discovery
Immunostep Immunostep has developed a revolutionary reagent for detecting CAR T cells, essential in cancer immunotherapy. This reagent, based on BrightStep™ technology, uses CD19 protein tagged with R-PE fluorochrome, enabling precise and rapid identification in any flow cytometer. With a simplified one-hour protocol and high resolution, this reagent surpasses previous product limitations, ensuring reliable and efficient results. This advancement places Immunostep at the forefront of biotechnology in the fight against cancer.
The rest of the information is available on the website.